¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"skin vascular permeability factor"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • galvanic skin response audiometry
    ÇǺÎÀü±â¹ÝÀÀû·Â°Ë»ç
  • glossy skin
    ±¤ÅÃÇǺÎ
  • gravitational skin line
    Áß·ÂÇǺμ±
  • hairy skin receptor
    ÅÐÇǺμö¿ë±â
  • leopard skin
    Ç¥¹üÇǺÎ
  • lizard skin
    µµ¸¶¹ìÇǺÎ
  • relaxed skin tension line
    ÇǺÎÇ®¸²¼±, ÇǺÎÀ̿ϼ±
  • source-skin distance
    ¿øÃµÇǺλçÀ̰Ÿ®, ¿øÃµÇǺΰ£°Å¸®
  • scalded skin syndrome
    È­»óÇǺÎÁõÈıº
  • split-thickness skin graft
    ºÎºÐÃþÇǺÎÀ̽Ä
  • staphylococcal scalded skin syndrome
    Æ÷µµ¾Ë±Õ¼º¿­»óÇǺÎÁõÈıº, Æ÷µµ±¸±Õ¼º¿­»óÇǺÎÁõÈıº
  • sailor¡¯s skin
    ¹î»ç¶÷ÇǺÎ
  • skin
    ÇǺÎ
  • skin appendage
    ÇǺκμӱâ(°ü)
  • skin care
    ÇǺΰü¸®
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • congestive skin
    ¿ïÇ÷ÇǺÎ
  • skin care
    ÇǺΰü¸®
  • dynamic skin line
    µ¿ÀûÇǺμ±
  • skin dose
    ÇǺμ±·®
  • source-skin distance
    ¼±¿øÇǺΰ£°Å¸®
  • target skin distance
    Ç¥ÀûÇǺΰŸ®
  • temperature-dependent skin disorder
    ¿ÂµµÀÇÁ¸ÇǺκ´
  • electric skin resistance
    ÇǺÎÀü±âÀúÇ×
  • farmer¡¯s skin
    ³óºÎÇǺÎ
  • skin flap
    ÇÇºÎÆÇ
  • skin flare
    ÇǺιßÀû
  • skin friction
    ÇǺθ¶Âû
  • galvanic skin reflex
    Àü±âÇǺιݻç
  • galvanic skin response
    Àü±âÇǺιÝÀÀ
  • glabrous skin
    Åоø´ÂÇǺÎ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Factor XII
    XII ÀÀ°íÀÎÀÚ(ëêͳì×í­)
  • Fibrin-stabilizing factor
    ¼¶À¯¼Ò¾ÈÁ¤ÀÎÀÚ(¡­äÌïÒì×í­)
  • Fibroblast growth factor
    ¼¶À¯¸ð¼¼Æ÷(àéë«Ù½á¬øà)¼ºÀå¿äÀÎ(à÷íþé©ì×)
  • G-CSF (Granulocyte colony-stimulating factor)
    °ú¸³¼¼Æ÷±ºÃËÁøÀÎÀÚ(Î¨Ø£á¬øàÏØõµòäì×í­)
  • GH releasing factor
    ¼ºÀå(à÷íþ)È£¸£¸ó À¯¸®ÀÎÀÚ(ë´×îì×í­).
  • GH releasing factor
    ¼ºÀåÈ£¸£¸óÀ¯¸®ÀÎÀÚ.
  • Growth factor
    ¼ºÀåÀÎÀÚ(à÷íþì×í­)
  • Hageman factor
    ÇϰԸ¸ÀÎÀÚ
  • Hydrostatic factor
    Á¤¼öÀÎÀÚ(ð¡â©ì×í­)
  • IGF-I(insulin-like growth factor-I)
    Àν¶¸° À¯»ç ¼ºÀåÀÎÀÚ-1
  • Luteinization -inhibiting factor
    Ȳüȭ¾ïÁ¦¿äÀÎ(üÜô÷ûùåäð¤é©ì×)
  • Macrophage colony-stimulating factor
    ´ë½Ä¼¼Æ÷Áý¶ôÇü¼ºÃËÁøÀÎÀÚ(ÓÞãÝá¬øàó¢Õªû¡à÷õµòäì×í­)à÷õµòäì×?
  • NGF=>nerve growth factor
    ½Å°æ¼ºÀåÀÎÀÚ
  • PAF =platelet activating factor
    Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ.
  • PAF= platelet activating factor
    Ç÷¼ÒÆÇ Ȱ¼ºÀÎÀÚ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • pulmonary vascular resistance
    ÆóÇ÷°üÀúÇ×(øËúìηî½ù÷), Æó¼øÈ¯ÀúÇ×.
  • renal vascular disorder
    ½ÅÇ÷°üÁúȯ
  • renal vascular injury
    ½Å Ç÷°ü¼Õ»ó
  • reticulate vascular nevus
    ¸Á»ó Ç÷°ü ¸ð¹Ý
  • reticulated vascular nevus
    ¸Á»ó Ç÷°ü ¸ð¹Ý
  • splanchnic vascular bed
    ³»ÀåÇ÷°ü¿µ¿ª(¡­úìηçÐæ´).
  • submucous vascular plexus
    Á¡¸·¹Ø¸Æ°ü¾ó±â
  • synthetic vascular graft
    ÇÕ¼ºÇ÷°ü(¡­úìη), ´ë¿ëÇ÷°ü(ÓÛéÄúìη).
  • total vascular resistance
    ÃÑÇ÷°üÀúÇ×(õÅúìη î½ù÷).
  • vascular
    ¸Æ°üÀÇ, Ç÷°üÀÇ.
  • vascular
    ¸Æ°ü(ØæÎ·)ÀÇ, Ç÷°üÀÇ
  • vascular anomaly
    Ç÷°ü ±âÇü
  • vascular bed
    Ç÷°ü»ó(úìηßÉ).
  • vascular bed
    Ç÷°ü»ó(ßÉ)
  • vascular bed
    Ç÷°ü»ó(Ç÷°ü»ó).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • factor ¥°
    ÀÎÀÚ(ì×í­) I
  • factor ¥±
    ÀÎÀÚ(ì×í­) II
  • factor ¥²
    ÀÎÀÚ(ì×í­) III
  • factor ¥³
    ÀÎÀÚ(ì×í­) IV
  • factor ¥´
    ÀÎÀÚ(ì×í­) V
  • factor ¥¶
    ÀÎÀÚ(ì×í­) VII
  • factor ¥·
    ÀÎÀÚ(ì×í­) VIII
  • factor ¥¸
    ÀÎÀÚ(ì×í­) IX
  • factor ¥¹
    ÀÎÀÚ(ì×í­) X
  • factor XI
    ÀÎÀÚ(ì×í­) XI
  • factor XII
    ÀÎÀÚ(ì×í­) XII
  • factor XIII
    ÀÎÀÚ(ì×í­) XIII
  • factor XIV
    ÀÎÀÚ(ì×í­) XIV
  • factor F
    ÀÎÀÚ(ì×í­) F
  • factor G
    ÀÎÀÚ(ì×í­) G
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
GRF gastrin-releasing factor; genetically related macrophage factor; gonadotropin-releasing factor; grow...
HSF heat shock factor; hepatocyte stimulatory factor; histamine sensitizing factor; human serum esterase...
LPF leukocytosis-promoting factor; leukopenia factor; lipopolysaccharide factor; localized plaque format...
MIF macrophage inhibitory factor; melanocyte[-stimulating hormone]-inhibiting factor; maximum inspirator...
MRF Markov random field; medical record file; melanocyte-[stimulating hormone]-releasing factor; mesence...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
PTP permeability transition pore
PTPC permeability transition pore complex
VEGF Vascular Endothelial Growth Factor
VEGFR-3 Vascular Endothelial Growth Factor Receptor-3
VEGFR Vascular Endothelial Growth Factor Receptors
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • flat skin plaque
    ÆíÆò ÇǺΠ¹Ý
  • focus skin distance
    ÃÊÁ¡ ÇǺΰ£ °Å¸®
  • hairy skin
    ¸ðÇÇ
    ¸Å²ô·´°í ºÎµå·¯¿î Áü½ÂÀÇ ÅÐ °¡Á×.
  • hyperpigmented skin
    °ú»ö¼Ò Ä§Âø ÇǺÎ
  • infantile stiff skin syndrome
    ¿µ¾Æ ÇǺΠ°æÁ÷ ÁõÈıº
  • marble skin
    ´ë¸®¼®¾ç ÇǺÎ
    È­¹ÝÀ̶ó°í ºÒ¸®´Â °ÍÀ¸·Î, °Ü¿ï¿¡ ³­·Î, È­·Î, °¢·Î µîÀÇ ³­¹æ±â±¸ÀÇ ¿Â¿­¿¡ ½ý¾î ¶ß°Å¿öÁ³´ø ºÎºÐ¿¡ ´ë¸®¼® ¹«´Ì¿Í °°Àº ±×¹°ÄÚ ¸ð¾çÀÇ Àû°¥»ö ¹ÝÀÌ ¹ß»ýÇÑ´Ù. º¯È­´Â Àϰú¼ºÀ̸ç, º½ÀÌ µÇ¸é Á¡Â÷·Î ¾ø¾îÁö´Â °ÍÀÌ º¸ÅëÀÌ´Ù. ¶ÇÇÑ °°Àº ¸ð¾çÀÇ º´º¯ÀÌ, °í¿ÂÀ» ½ý´Â Á÷¾÷¿¡ Á¾»çÇÏ´Â »ç¶÷ÀÇ ³ëÃâµÈ ÇǺο¡ ¹ß»ýÇÏ´Â °æ¿ì°¡ ÀÖ´Ù
  • outer skin
    ¿ÜÇǺÎ
  • positive skin test
    ¾ç¼º ÇǺνÃÇè
  • sailors' skin
    ¼öºÎ ÇǺÎ
    Àϱ¤¿¡ °úÀ× ³ëÃâµÊÀ¸·Î½á ÀÏÂï ³ëÈ­µÈ ÇǺημ­, ź·Â ¼¶À¯Áõ, À§Ãà, ¸ð¼¼Ç÷°ü È®ÀåÁõ ¹× Àϰü¼º °¢ÁúÃþÀ» ¼ö¹ÝÇϸç, ¶§·Î´Â ¾ÏÀ» ÀÏÀ¸Å²´Ù. ƯÈ÷ °í¿î ÇǺθ¦ °¡Áø »ç¶÷¿¡°Ô¼­ º¼ ¼ö ÀÖ´Ù.
  • scalded skin syndrome
    Ç¥ÇÇ ¹Ú¸® ÁõÈıº
    Ȳ»ö Æ÷µµ ±¸±ÕÀÇ Ç¥ÇÇ ¹Ú¸® µ¶¼Ò¿¡ ÀÇÇÑ ÇǺκ´À¸·Î, ÀÌ ÁúȯÀÇ ÀÓ»ó Áõ»óÀº ÀÌ µ¶¼Ò¿¡ ±âÀÎÇϸç Ȳ»ö Æ÷µµ ±¸±Õ °¨¿° ±× ÀÚü¿¡ ÀÇÇÑ ¿µÇâ°ú´Â ±¸ºÐµÈ´Ù. 3°¡Áö ÀÓ»óÀû Áõ»óÀ¸·Î´Â, Àü½Å¼º Ç¥¸® ¹Ú¸®¼º ÇǺο°, Bullous im
  • senile skin
    ³ëÀÎ ÇǺÎ
  • skin
    ÇǺÎ
    1. ÀÎüÀÇ Ç¥¸éÀ» µ¤°í ÀÖ´Ù. ¿Ü¹è¿±¿¡¼­ À¯·¡. ¼ÕÅé, ¹ßÅé, ÅÐ ¹× ÇǺΠ»ùµéÀº ÇǺο¡¼­ À¯·¡µÈ ºÎ¼Ó ±â°ü. Ư¼ö ±¸Á¶È­µÈ »óÇÇ, Áï Ç¥ÇÇ
  • skin adnexa
    ÇǺΠºÎ¼Ó±â
  • skin appendage
    ÇǺΠºÎ¼Ó±â
  • skin bloom
    ¹ßÁøÀÇ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
vascular spider spider angioma
vascular-streak dieback A fungal disease of the cacaotree caused by Oncobasidium theobromae.
(09 Oct 1997)
vascular stripe The stratified epithelium lining the upper part of the ligamentum spirale cochleae; it is penetrated by capillaries and is believed to be the site of production of endolymph.
Synonym: stria vascularis ductus cochlearis, psalterial cord, vascular stripe.
(05 Mar 2000)
vascular surgeon A physician specialist expert in the surgical management of occlusive diseases of the blood vessels.
(27 Sep 1997)
vascular surgery A branch of medicine dealing with the use of surgery to diagnose/treat diseases of the blood vessels.
(09 Oct 1997)
vascular surgical procedures Operative procedures for the treatment of vascular disorders.
(12 Dec 1998)
vascular system The cardiovascular and lymphatic system's collectively.
Synonym: circulatory system.
(05 Mar 2000)
vascular tunic of eye The vascular, pigmentary, or middle coat of the eye, comprising the choroid, ciliary body, and iris.
Synonym: tunica vasculosa bulbi, Haller's tunica vasculosa, tunica vasculosa oculi, uvea, uveal tract.
(05 Mar 2000)
vascular zone An area in the external acoustic meatus where a number of minute blood vessels enter from the mastoid bone.
Synonym: spongy spot, zona vasculosa.
(05 Mar 2000)
resistance, vascular The opposition to the flow of blood across a vascular bed.
(12 Dec 1998)
mesenteric vascular occlusion Obstruction of the flow in the mesenteric circulation by atherosclerosis, emboli or thrombi, stenosis, trauma, and compression or intrinsic pressure from adjacent tumours. Rare causes are drugs, intestinal parasites, and vascular immunoinflammatory diseases such as periarteritis nodosa and thromboangiitis obliterans.
(12 Dec 1998)
peripheral vascular disease A term used to describe progressive occlusive disease of the arteries that supply the extremities. Risk factors include atherosclerosis and diabetes.
(27 Sep 1997)
peripheral vascular diseases General or unspecified diseases of the blood vessels outside the heart. It is for diseases of the peripheral as opposed to the cardiac circulation.
(12 Dec 1998)
choroidal vascular atrophy Atrophy affecting either all choroidal vessels or only the choriocapillaris, occurring either diffusely or confined to the posterior pole of the eye.
(05 Mar 2000)
collagen-vascular diseases A group of generalised disease's affecting connective tissue and frequently characterised by fibrinoid necrosis or vasculitis; in some collagen disease's, auto-immunization, particularly antinuclear antibodies, has been shown and circulating immune complexes are found. The term is not entirely acceptable because there is no evidence that collagen is primarily involved; "collagen" was once synonymous with "connective tissue" rather than describing a specific fibrinous protein in that tissue.
See: connective-tissue diseases.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á